News Author: Jennifer Smith Publish date: January 20, 2020
Patients transplanted in recent years were older and sicker at baseline but had better outcomes than did patients transplanted in the mid-2000s.
News Author: Jennifer Smith Publish date: January 20, 2020
Review authors suggest cardiovascular patients may benefit from cannabis screening and testing.
News Author: Jennifer Smith Publish date: January 17, 2020
People traveling from Wuhan, China, to New York (JFK), San Francisco (SFO), and Los Angeles (LAX) airports will be screened for symptoms associated...
News Author: Jennifer Smith Publish date: January 16, 2020
ORLANDO – A chart review revealed a lack of information on heavy menstrual bleeding for most women on oral antico...
News Author: Jennifer Smith Publish date: January 14, 2020
ORLANDO - Responses were best among transfusion-dependent patients who received CPI-0610 and ruxolitinib.
News Author: Jennifer Smith Publish date: January 14, 2020
The guidelines include recommendations for managing pediatric Burkitt lymphoma and diffuse large B-cell lymphoma.
News Author: Jennifer Smith Publish date: January 14, 2020
This is the first study to show that 9/11 responders have a higher incidence of leukemia than the general population.
Article Author: Jennifer Smith Publish date: January 13, 2020
Five breast cancer researchers have won up to $1.4 million in funding from the National Comprehensive Cancer Network and Pfizer.
News Author: Jennifer Smith Publish date: January 13, 2020
Postmenopausal patients with node-positive breast cancer were more likely to have locoregional recurrence if they had intermediate or high recurren...
News Author: Jennifer Smith Publish date: January 9, 2020
There was no significant difference in global IQ at 12 months between patients who underwent adenotonsillectomy and those who did not.
News Author: Jennifer Smith Publish date: January 9, 2020
ORLANDO – Navitoclax plus ruxolitinib decreased spleen volume, reduced bone marrow fibrosis, and improved total symptom scores in patients with pri...
News Author: Jennifer Smith Publish date: January 7, 2020
ORLANDO – There were no cases of severe cytokine release syndrome or severe neurotoxicity reported with the anti-CD5 chimeric antigen receptor T ce...
Article Author: Jennifer Smith Publish date: December 30, 2019
Plus, a clinical trials expert joins St. Jude, ISGIO names a new president-elect, and ASCO gets a new board member.
News Author: Jennifer Smith Publish date: December 27, 2019
Maintenance treatment improved progression-free survival, but not overall survival, compared with observation.
News Author: Jennifer Smith Publish date: December 23, 2019
ORLANDO – All 10 patients responded to anti-BCMA CAR T-cell therapy, including 3 patients who had previously failed BCMA-directed therapy.
